Clinical Trial Update: Brentuximab Vedotin with Adriamycin, Vinblastine and Dacarbazine for Patients Aged 18-59 Years with Untreated Advanced-stage Classical Hodgkin Lymphoma: a Real-life Experience

View source ↗

Summary

This clinical trial update reports real-world use of Brentuximab Vedotin with ABVD chemotherapy in untreated advanced-stage classical Hodgkin lymphoma patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma Classical

Drugs mentioned

• Adriamycin (doxorubicin)
• Brentuximab vedotin (Brentuximab vedotin)
• DTIC-Dome (dacarbazine)
• Vinblastine (vinblastine)

Snippet

Sponsor: Federico II University | Conditions: Classic Hodgkin Lymphoma, Advanced Hodgkin Lymphoma | Status: COMPLETED